This finding is consistent with the observations that in neovascular age-related macular degeneration, the complexity of the neovascularization diminishes after anti-VEGF therapy, whereas the larger, more mature vessels are unchanged (37, 38). Here, VEGFA is linked to age-related macular degeneration.